Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, +26

New England Journal of Medicine

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto

Sibylle Loibl, Karsten E. Weber, Kirsten M. Timms, +24

Annals of Oncology

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

Andreas du Bois, Philipp Harter, Christina Fotopoulou, +10

International Journal of Gynecological Cancer

MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

Bradley J. Monk, Rachel N. Grisham, Susana Banerjee, +27

Journal of Clinical Oncology

Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial

Michael Friedländer, Val Gebski, Emma Gibbs, +19

The Lancet Oncology

Olaparib MaintenanceHealth-related QualityMedicineCancer ManagementGynecology +7

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

Philipp Harter, Jan Hauke, Florian Heitz, +34

PLoS ONE

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Amit M. Oza, Ursula A. Matulonis, Susanne Malander, +17

The Lancet Oncology

MedicineCancer ManagementGynecologyRecurrent Ovarian CancerNiraparib Versus Placebo +5

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Radoslav Chekerov, Felix Hilpert, Sven� Mahner, +27

The Lancet Oncology

OncologyMedicineMetronomic TherapyClinical TrialsGynecology +6

Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry

Isabell Witzel, Elena Laakmann, Rudolf Weide, +16

European Journal of Cancer

Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up

Sorin Giuşcă, Grigorios Korosoglou, Moritz Montenbruck, +8

Circulation Cardiovascular Imaging